. Author manuscript; available in PMC: 2017 Dec 15.

Published in final edited form as: Phytomedicine. 2016 Oct 24;23(14):1699–1705. doi: 10.1016/j.phymed.2016.10.013

Table 1.

Baseline characteristics of study subjects (n = 179)

Baseline Characteristics	No. (%) or Mean (SD)
Age	45.7 (15.3), range (19.7 to 78.3)
Gender (% Female)	119 (66.5%)
Race (% Caucasian)	134 (74.9%)
Ethnicity (% Hispanic)	8 (4.5%)
% Unemployed	31 (17.3%)
% Married	67 (37.4%)
Age at first GAD episode	21.5 (15.4)
Duration of current GAD episode (years)	8.4 (13.9)
% Current major depressive episode	56 (31.3%)
Number of psychiatric co-morbidities	0.7 (0.9)
Number of previous treatments for GAD	1.5 (1.7)
GAD-7	15.1 (3.1)
HAM-A	14.7 (3.6)
BAI	16.9 (9.4)
PGWB-Anxiety	9.3 (3.9)
CGI-S	4.2 (0.4)

BAI = Beck Anxiety Inventory; CGI-S = Clinical Global Impression–Severity; GAD-7 = Generalized Anxiety Disorder 7-Item Scale; HAM-A = Hamilton Rating Scale for Anxiety; PGWB = Psychological General Well Being.